Side Effects: The Hidden Agenda of the Pharmaceutical Drug Cartel

Side Effects: The Hidden Agenda of the Pharmaceutical Drug Cartel PDF Author:
Publisher: Present Time Books
ISBN: 0981910106
Category : Pharmaceutical industry
Languages : en
Pages : 269

Get Book Here

Book Description

Side Effects: The Hidden Agenda of the Pharmaceutical Drug Cartel

Side Effects: The Hidden Agenda of the Pharmaceutical Drug Cartel PDF Author:
Publisher: Present Time Books
ISBN: 0981910106
Category : Pharmaceutical industry
Languages : en
Pages : 269

Get Book Here

Book Description


Problem-Free Diabetes

Problem-Free Diabetes PDF Author: Frank Suarez
Publisher: Metabolic Technology Center
ISBN: 0988221888
Category : Health & Fitness
Languages : en
Pages : 574

Get Book Here

Book Description
Practical recommendations for improving diabetes and its related conditions. Includes information on how candida albicans, a yeast, can affect diabetics, the 3x1 Diet® for diabetics, how to find aggressor foods that can spike up blood glucose levels, how to read tricky labels, the truth about cholesterol, what to do when blood glucose levels are resistive and won't go down, natural supplements that can help a diabetic, the sleep patterns that affect diabetes, foods that benefit a diabetic condition and more. This book has hundreds of pages on the subject of diabetes and what practical recommendations you can start applying immediately to improve your condition and get it under control. The intent of the book is to explain in simple terms what most medical or technical books detail in a confusing or incomprehensible way. It emphasizes the metabolism as the principle factor to address and improve in order to improve diabetes. The premise of the book is PRACTICALITY, things to DO and IMPLEMENT immediately to start seeing results and measuring more desirable glucose levels immediately.

Let's Stop the #1 Killer of Americans Today

Let's Stop the #1 Killer of Americans Today PDF Author: Harry A. Elwardt
Publisher: Author House
ISBN: 1467822884
Category : Science
Languages : en
Pages : 322

Get Book Here

Book Description
Even with Americas most advanced surgical procedures and pharmaceutical drugs, nearly one million Americans are still dying every year of heart disease. We are failing miserably at stopping this silent killer, which is not just a man problem; in fact, 500,000 women fall victim to heart disease each year, dwarfing breast cancer. Heart Disease, which costs the American public over 298 billion dollars a year, is just one form of cardiovascular disease, others include: hypertension, high cholesterol, diabetes, coronary artery disease, peripheral artery disease, congenital heart disease, congestive heart failure and stroke. Dr. Harry Elwardt is a doctor of naturopathy with a Ph.D. in health and nutrition. He believes there is no reason for this killer to rule the day. That through education of the causes of cardiovascular disease, the use of the latest in early detection devices, and the implementation of a good diet, exercise and nutritional supplement program, heart disease numbers can begin to decline in America. We may be winning the war on terror, but we are losing the war against this illusive enemy. Dont wait until you or someone you love fall victim to this ruthless killer. Dr. Harry Elwardt has declared war on heart disease and in this book he lays out a strategic plan of attack. He believes it is the choices we make right now, not leaving it to chance, that determines our wellness and our destiny! Wont you join him in turning the tide in this covert war against the American people?

Corporate Crime in the Pharmaceutical Industry (Routledge Revivals)

Corporate Crime in the Pharmaceutical Industry (Routledge Revivals) PDF Author: John Braithwaite
Publisher: Routledge
ISBN: 1135072906
Category : Social Science
Languages : en
Pages : 451

Get Book Here

Book Description
First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.

The Global Politics of Pharmaceutical Monopoly Power

The Global Politics of Pharmaceutical Monopoly Power PDF Author: Ellen F. M. 't Hoen
Publisher:
ISBN: 9789079700066
Category : Agreement on Trade-Related Aspects of Intellectual Property Rights
Languages : en
Pages : 136

Get Book Here

Book Description
In The Global Politics of Pharmaceutical Monopoly Power, researcher and global advocate Ellen 't Hoen explains how new global rules for pharmaceutical patenting impact access to medicines in the developing world. The book gives an account of the current debates on intellectual property, access to medicines, and medical innovation, and provides historical context that explains how the current system emerged. This book supports major policy changes in the management of pharmaceutical patents and the way medical innovation is financed in order to protect public health and, in particular, promote access to essential medicines for all. The Open Society Institute provided support to translate this report into Russian.

Pharmaceuticals, Corporate Crime and Public Health

Pharmaceuticals, Corporate Crime and Public Health PDF Author: Graham Dukes
Publisher: Edward Elgar Publishing
ISBN: 1783471107
Category : Business & Economics
Languages : en
Pages : 419

Get Book Here

Book Description
The pharmaceutical industry exists to serve the community, but over the years it has engaged massively in corporate crime, with the public footing the bill. This readable study by experts in medicine, law, criminology and public health documents the pr

Collapse of Drugs Due to Wellness

Collapse of Drugs Due to Wellness PDF Author: David Tippie
Publisher: Lulu.com
ISBN: 0557558107
Category : Health & Fitness
Languages : en
Pages : 325

Get Book Here

Book Description
Wellness not an entitlement! Achieved daily through effort and lifestyle change. Chronological aging is natural! Biological aging is a result of poor choices made every day. The body is designed to heal itself and only you can stop it. Your body rejects processed food, synthetics and drugs are synthetics. Can't achieve wellness without the correct supplementation due to our green harvested food supply. Sedentary is a death wish; you must move to improve health and increase longevity. The correct water is just as important as the correct amount of water intake. Learn how high alkaline water reduces acidity. Learn every disease starts in an acidic environment. Learn why cancer is only the symptom of the underlying disease, wrongly treated by drugs & chemo. Life circumstances inspired author to write. Learn what he revealed after shining the light in dark areas of the medical pharmaceutical sickness industry and on the FDA who are limiting health & creating a drug monopoly, but you can decide.

The Influence of the Pharmaceutical Industry

The Influence of the Pharmaceutical Industry PDF Author: Great Britain: Parliament: House of Commons: Health Committee
Publisher: The Stationery Office
ISBN: 9780215024572
Category : Political Science
Languages : en
Pages : 556

Get Book Here

Book Description
Incorporating HC 1030-i to iii.

The Truth About the Drug Companies

The Truth About the Drug Companies PDF Author: Marcia Angell
Publisher: Random House Trade Paperbacks
ISBN: 0375760946
Category : Business & Economics
Languages : en
Pages : 354

Get Book Here

Book Description
During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices. Now, in this bold, hard-hitting new book, Dr. Angell exposes the shocking truth of what the pharmaceutical industry has become–and argues for essential, long-overdue change. Currently Americans spend a staggering $200 billion each year on prescription drugs. As Dr. Angell powerfully demonstrates, claims that high drug prices are necessary to fund research and development are unfounded: The truth is that drug companies funnel the bulk of their resources into the marketing of products of dubious benefit. Meanwhile, as profits soar, the companies brazenly use their wealth and power to push their agenda through Congress, the FDA, and academic medical centers. Zeroing in on hugely successful drugs like AZT (the first drug to treat HIV/AIDS), Taxol (the best-selling cancer drug in history), and the blockbuster allergy drug Claritin, Dr. Angell demonstrates exactly how new products are brought to market. Drug companies, she shows, routinely rely on publicly funded institutions for their basic research; they rig clinical trials to make their products look better than they are; and they use their legions of lawyers to stretch out government-granted exclusive marketing rights for years. They also flood the market with copycat drugs that cost a lot more than the drugs they mimic but are no more effective. The American pharmaceutical industry needs to be saved, mainly from itself, and Dr. Angell proposes a program of vital reforms, which includes restoring impartiality to clinical research and severing the ties between drug companies and medical education. Written with fierce passion and substantiated with in-depth research, The Truth About the Drug Companies is a searing indictment of an industry that has spun out of control.

Mexico

Mexico PDF Author: June S Beittel
Publisher:
ISBN: 9781655345715
Category :
Languages : en
Pages : 38

Get Book Here

Book Description
Mexican drug trafficking organizations (DTOs) pose the greatest crime threat to the United States and have "the greatest drug trafficking influence," according to the annual U.S. Drug Enforcement Administration's (DEA's) National Drug Threat Assessment. These organizations work across the Western Hemisphere and globally. They are involved in extensive money laundering, bribery, gun trafficking, and corruption, and they cause Mexico's homicide rates to spike. They produce and traffic illicit drugs into the United States, including heroin, methamphetamine, marijuana, and powerful synthetic opioids such as fentanyl, and they traffic South American cocaine. Over the past decade, Congress has held numerous hearings addressing violence in Mexico, U.S. counternarcotics assistance, and border security issues. Mexican DTO activities significantly affect the security of both the United States and Mexico. As Mexico's DTOs expanded their control of the opioids market, U.S. overdoses rose sharply to a record level in 2017, with more than half of the 72,000 overdose deaths (47,000) involving opioids. Although preliminary 2018 data indicate a slight decline in overdose deaths, many analysts believe trafficking continues to evolve toward opioids. The major Mexican DTOs, also referred to as transnational criminal organizations (TCOs), have continued to diversify into such crimes as human smuggling and oil theft while increasing their lucrative business in opioid supply. According to the Mexican government's latest estimates, illegally siphoned oil from Mexico's state-owned oil company costs the government about $3 billion annually. Mexico's DTOs have been in constant flux. In 2006, four DTOs were dominant: the Tijuana/Arellano Felix organization (AFO), the Sinaloa Cartel, the Juárez/Vicente Carillo Fuentes Organization (CFO), and the Gulf Cartel. Government operations to eliminate DTO leadership sparked organizational changes, which increased instability among the groups and violence. Over the next dozen years, Mexico's large and comparatively more stable DTOs fragmented, creating at first seven major groups, and then nine, which are briefly described in this report. The DEA has identified those nine organizations as Sinaloa, Los Zetas, Tijuana/AFO, Juárez/CFO, Beltrán Leyva, Gulf, La Familia Michoacana, the Knights Templar, and Cartel Jalisco-New Generation (CJNG). In mid-2019, leader of the long-dominant Sinaloa Cartel, Joaquin ("El Chapo") Guzmán, was sentenced to life in a maximum-security U.S. prison, spurring further fracturing of a once hegemonic DTO. By some accounts, a direct effect of this fragmentation has been escalated levels of violence. Mexico's intentional homicide rate reached new records in 2017 and 2018. In 2019, Mexico's national public security system reported more than 17,000 homicides between January and June, setting a new record. In the last months of 2019, several fragments of formerly cohesive cartels conducted flagrant acts of violence. For some Members of Congress, this situation has increased concern about a policy of returning Central American migrants to cities across the border in Mexico to await their U.S. asylum hearings in areas with some of Mexico's highest homicide rates. Mexican President Andrés Manuel López Obrador, elected in a landslide in July 2018, campaigned on fighting corruption and finding new ways to combat crime, including the drug trade. According to some analysts, challenges for López Obrador since his inauguration include a persistently ad hoc approach to security; the absence of strategic and tactical intelligence concerning an increasingly fragmented, multipolar, and opaque criminal market; and endemic corruption of Mexico's judicial and law enforcement systems. In December 2019, Genero Garcia Luna, a former top security minister under the Felipe Calderón Administration (2006-2012), was arrested in the United States on charges he had taken enormous bribes from the Sinaloa Cartel.